Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes
| dc.contributor.author | Bobronnikova, Lesya | |
| dc.date.accessioned | 2017-11-04T12:56:59Z | |
| dc.date.available | 2017-11-04T12:56:59Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | To determine the impact of galectin-3 levels on the progression of metabolic disorders and structural-functional changes in the myocardium and blood vessels in patients with concomitant systemic arterial hypertension (AH) and type 2 diabetes mellitus (type 2 DM). | ru_RU |
| dc.identifier.citation | Bobronnikova L. R. Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes / L. R. Bobronnikova // Vessel Plus. – 2017. – № 1. – Р. 61–67. – DOI: 10.20517/2574-1209.2016.10. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/17956 | |
| dc.language.iso | en | ru_RU |
| dc.subject | arterial hypertension | ru_RU |
| dc.subject | type 2 diabetes | ru_RU |
| dc.subject | insulin resistance | ru_RU |
| dc.subject | cardiovascular remodeling | ru_RU |
| dc.subject | galectin-3 | ru_RU |
| dc.title | Galectin-3 as a potential biomarker of metabolic disorders and cardiovascular remodeling in patients with hypertension and type 2 diabetes | ru_RU |
| dc.type | Article | ru_RU |